PHARMACY

Pow!

BY DSN STAFF

85% — that’s more or less the combined market share for the companies that make up the 2011 DSN PoweRx50, approximately $185 billion of the total $218 billion retail pharmacy industry. Numbering almost 50,000 stores among them, or more than 8-of-10 of all the pharmacies in the United States — BAM! — the DSN PoweRx50 indisputably reflects the true titans of the retail pharmacy industry.


What makes the DSN PoweRx50 different? The DSN PoweRx50 is the ONLY truly CHANNEL-AGNOSTIC ranking of the retail pharmacy industry that truly measures all of retail pharmacy, including traditional drug chains, independents, supermarkets, mass and club stores — ALL of it. BA-BOOM!


Why do we do it that way? Because everybody sells everything everybody else sells, and everyone shops everywhere for everything. Traditional drug stores fighting for a share of that business no longer can afford to worry ONLY about competing with other drug stores. Vendors looking to maximize distribution for their products no longer can afford a myopic, single-channel view of the business. The lines that once defined the different classes of trade haven’t just blurred — they’re GONE. 


The DSN PoweRx50 measures all of these very different companies by the one metric that matters — pharmacy sales — and the relative commitment of senior management to growing share of pharmacy, health and wellness. KA-POW!

For the full DSN PoweRx50 Annual Report 2011, click here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Logos are in the eye of the beholder

BY Rob Eder

WHAT IT MEANS AND WHY IT’S IMPORTANT — Another story this week is a reminder of how important even the most subtle finesses of a corporate logo can be in the minds of the consumer.

(THE NEWS: Wegmans leaves ‘circle W’ to Walgreens. For the full story, click here)

The creator of the CVS/pharmacy logo died earlier this week. The story was a reminder of how powerful three letters and a ‘forward-slash’ can be. The now iconic logo was instrumental in the rebranding of the original Consumer Value Store as CVS, and what that meant in terms of the shift from a value-driven health and beauty aids/general merchandise store to a pharmacy. Today those three letters have become somewhat synonymous with the word "pharmacy" in the minds of consumers.

It also reminds DSN of another entertaining story about how the former super-regional chain known as Longs (now part of CVS) came to drop the apostrophe in its name: the signs were $50 cheaper without the punctuation mark, a savings founders Thomas and Joseph Long couldn’t pass up.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Report: Many Type 1 diabetics have other immune diseases

BY Alaric DeArment

NEW YORK — Many children with Type 1 diabetes have other autoimmune disorders as well, according to published reports.

Citing findings in a recent study of nearly 500 children published in the journal Diabetes Care, Reuters reported that one-third of children with the disease — an autoimmune disorder in which the immune system attacks the cells of the pancreas — also have such disorders as celiac disease, autoimmune thyroid disease and a disorder of the adrenal glands called Addison’s disease.

For example, one-quarter of the children had antibodies related to thyroid disease, while one-eighth of those children had the disease; one-eighth of the children had the antibodies for celiac disease, while one-quarter of those children had the disease.

About 25.8 million Americans have diabetes, and Type 1 diabetes accounts for about 5% of all diagnosed cases in adults, according to the National Diabetes Information Clearinghouse, part of the National Institutes of Health.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?